Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...
Q4 2025 earnings call recap: 2026 revenue/EBITDA guidance, AI-driven cost cuts, ARR/retention trends, and new markets—read now.
Cameco (TSX: CCO; NYSE: CCJ) reported today that it filed its annual report on Form 40-F with the US Securities and Exchange Commission. The document includes Cameco’s audited annual financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results